New Cleveland Clinic research reveals that up to 5% of Americans – approximately 17 million people – carry genetic mutations or "variants" linked to increased cancer susceptibility, regardless of risk ...
A new study headed by teams at the Wellcome Sanger Institute, EMBL’s European Bioinformatics Institute (EMBL-EBI), and Open Targets has indicated how mutations that cause cancer drug resistance fall ...
Proteogenomics explores how genetic information translates into protein expression and function, and the role of changes across DNA, RNA, and proteins in influencing disease development and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback